Loading
NYSEHealthcareMedical - Diagnostics & Research
Latest quote
$228.06
+$1.00 · +0.44%
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Regular session
$228.06
+$1.00 · +0.44%
Regular session · ET · Market data may be delayed.
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Day range
Current $228.06
52-week range
Current $228.06
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
89
Deep Value
Sentiment
68
Bullish
Risk
17
Low Risk
Momentum
46
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Day range
Current $228.06
52-week range
Current $228.06
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.04B USD | 9.87B USD | 9.25B USD | 9.88B USD | 10.79B USD |
| Cost of goods sold | 7.51B USD | 6.63B USD | 6.2B USD | 6.45B USD | 6.58B USD |
| Gross profit | 3.52B USD | 3.24B USD | 3.07B USD | 3.43B USD | 4.21B USD |
| Selling, general, and administrative | 1.97B USD | 1.77B USD | 1.62B USD | 1.87B USD | 1.73B USD |
| Operating expenses | 1.92B USD | 1.9B USD | 1.81B USD | 2.01B USD | 1.83B USD |
| Interest income | 13M USD | 25M USD | 11M USD | 10M USD | 1M USD |
| Interest expense | 277M USD | 226M USD | 163M USD | 148M USD | 152M USD |
| Depreciation and amortization | 570M USD | 493M USD | 439M USD | 437M USD | 408M USD |
| Operating income | 1.6B USD | 1.35B USD | 1.26B USD | 1.43B USD | 2.38B USD |
| Net income | 992M USD | 871M USD | 854M USD | 946M USD | 2B USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$250
9.62% upsideCash distributions grouped by calendar year; partial years are marked.
$3.15
2025 complete year+30.2% since 2021
2026 partial: $3.38
$2.42
2,021
$3.26
2,022
$2.79
2,023
$2.96
2,024
$3.15
2,025
$3.38
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Oct 6, 2026 | $0.86Quarterly | Oct 6, 2026 | Oct 21, 2026 |
Dividend | Jul 8, 2026 | $0.86Quarterly | Jul 8, 2026 | Jul 22, 2026 |
Dividend | Apr 6, 2026 | $0.86Quarterly | Apr 6, 2026 | Apr 20, 2026 |
Dividend | Jan 13, 2026 | $0.80Quarterly | Jan 13, 2026 | Jan 28, 2026 |
Dividend | Oct 3, 2025 | $0.80Quarterly | Oct 3, 2025 | Oct 20, 2025 |
Dividend | Jul 7, 2025 | $0.80Quarterly | Jul 7, 2025 | Jul 21, 2025 |
Ex-dividend Oct 6, 2026
$0.86
Quarterly
Record Oct 6, 2026 · Payment Oct 21, 2026
Ex-dividend Jul 8, 2026
$0.86
Quarterly
Record Jul 8, 2026 · Payment Jul 22, 2026
Ex-dividend Apr 6, 2026
$0.86
Quarterly
Record Apr 6, 2026 · Payment Apr 20, 2026
Ex-dividend Jan 13, 2026
$0.80
Quarterly
Record Jan 13, 2026 · Payment Jan 28, 2026
Ex-dividend Oct 3, 2025
$0.80
Quarterly
Record Oct 3, 2025 · Payment Oct 20, 2025
Ex-dividend Jul 7, 2025
$0.80
Quarterly
Record Jul 7, 2025 · Payment Jul 21, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR S&P 500 ETF1557.T48.55B0.04%129.41T JPY0.09%¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI845.26M0.04%2.3T USD0.03%$379.45-0.41%
Vanguard S&P 500 ETFVOO706.69M0.04%1.8T USD0.03%$711.82-0.35%
Vanguard Morningstar Mid-Cap ETFVO575.38M0.25%226.4B USD0.03%$79.925-0.27%
iShares Core S&P 500 ETFIVV333.45M0.04%899.63B USD0.03%$777.78-0.36%
State Street SPDR S&P 500 ETFSPY306.91M0.04%819.04B USD0.09%$774.36-0.37%
Vanguard Morningstar Value ETFVTV254.05M0.10%262.4B USD0.03%$217.85-0.16%
Invesco S&P 500 Equal Weight ETFRSP188.45M0.20%96.47B USD0.20%$210.18-0.20%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Mid-Cap ETFVOiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Morningstar Value ETFVTVInvesco S&P 500 Equal Weight ETFRSPAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
